Agenda: Investors Keep Up the Pressure on Political Disclosure
Spending misalignment is raising investors’ ire.
STAT+: Amid concerns over U.S. democracy, pharma financed committees that support election deniers
Some candidates continue to deny the results of the 2020 presidential elections…